SureTrader Stock Hero Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 4/26/2015 7:38:30 PM - Followers: 1222 - Board type: Free - Posts Today: 0
PostSubject
#190508  Sticky Note CLDN: I appreciate it. Honestly, this is exactly where poorgradstudent 04/26/15 07:38:30 PM
#190504  Sticky Note CLDN: Celladon Reports Negative Results for CUPID2 Trial jq1234 04/26/15 04:54:52 PM
#190499  Sticky Note Re #HCV and GILD, ABBV, BMY, and JNJ Rocky3 04/26/15 02:05:14 PM
#190492  Sticky Note ABBV abstract re VL and outcomes - has dewophile 04/26/15 08:01:11 AM
#190466  Sticky Note addendum to the MRK data: dewophile 04/24/15 10:07:18 PM
#190362  Sticky Note Not a comparable situation. There was a huge DewDiligence 04/23/15 04:21:48 PM
#190508   CLDN: I appreciate it. Honestly, this is exactly where poorgradstudent 04/26/15 07:38:30 PM
#190507   It appears they now have $150+ Million. Is hptaxis 04/26/15 05:33:47 PM
#190506   Nice call! CC tomorrow at 8:30am ET, but DewDiligence 04/26/15 05:05:48 PM
#190504   CLDN: Celladon Reports Negative Results for CUPID2 Trial jq1234 04/26/15 04:54:52 PM
#190503   The drug interaction charts are great.They are handy DewDiligence 04/26/15 04:52:11 PM
#190502   [OT]—Foreign-currency quiz: #msg-113114159. DewDiligence 04/26/15 04:44:32 PM
#190501   Roy has my meaning. Regulatory as in zipjet 04/26/15 04:26:51 PM
#190500   MRK’s slide set from ‘C-EDGE TN’ study (for DewDiligence 04/26/15 04:15:27 PM
#190499   Re #HCV and GILD, ABBV, BMY, and JNJ Rocky3 04/26/15 02:05:14 PM
#190498   Chris, I correct my error in a response vinmantoo 04/26/15 02:01:19 PM
#190497   The aim is to counter MRK’s pursuit of DewDiligence 04/26/15 12:48:03 PM
#190496   Purpose (FROM ABBVIE’S PHASE 3B RUBY-I STUDY) caravon 04/26/15 12:36:50 PM
#190495   April 24, 2015 7:57 PM caravon 04/26/15 11:25:57 AM
#190494   AKBA, CBYL, CBMX all heavy recent insider buying PennyMoocher69 04/26/15 10:40:58 AM
#190493   AMDA:look at the Cascade trial results alexander77 04/26/15 09:47:36 AM
#190492   ABBV abstract re VL and outcomes - has dewophile 04/26/15 08:01:11 AM
#190491   Quote: …PGNX gets a 50-60% split of [EU] revenues Carl Chris 04/26/15 02:08:48 AM
#190490   MRK cirrhotic data and more thoughts on the dewophile 04/25/15 10:44:16 PM
#190489   PTBI closes Private placement for $7M tpizzazz24 04/25/15 07:19:06 PM
#190488   One of those companies could conceivably be interested, DewDiligence 04/25/15 06:41:59 PM
#190487   I could see Pfizer, Glaxo or Sanofi controlling jbog 04/25/15 06:36:06 PM
#190486   You’re right—the AKBA director bought shares via the DewDiligence 04/25/15 05:18:44 PM
#190485   Akebia Therapeutics Announces Closing of Public Offering and hptaxis 04/25/15 05:10:42 PM
#190484   >>AKBA independent director buys $3.5M of stock on biomaven0 04/25/15 04:56:59 PM
#190483   The FDA is there to serve the drug whatisthecolorofmone 04/25/15 04:25:33 PM
#190482   Amen.Sad truth. Rather an inferior treatment than no linhdtu 04/25/15 04:11:28 PM
#190481   ABBV’s MALACHITE-1/2 studies comparing V-Pak to Incivek (#msg-94927196) DewDiligence 04/25/15 03:37:09 PM
#190480   PPHM weekend laugher: DewDiligence 04/25/15 03:23:19 PM
#190479   Re: TEVA/MYL—“Regulatory blockage” genisi 04/25/15 03:14:11 PM
#190478   Very interesting. Thanks for posting it. I had lgonber 04/25/15 02:05:26 PM
#190477   images.investorshub.advfn.com/images/uploads/2015/4/25/ymbegTEVA1.png[/ch DewDiligence 04/25/15 02:04:14 PM
#190476   TEVA/MYL—“Regulatory blockage” as in objections from antitrust regulators. DewDiligence 04/25/15 01:53:14 PM
#190475   AKBA independent director buys $3.5M of stock on DewDiligence 04/25/15 01:49:09 PM
#190474   Just in case, anybody was wondering, I was Double_Bagel 04/25/15 12:33:40 PM
#190473   So, HBV and HCV has been solved. Replicor Double_Bagel 04/25/15 12:04:37 PM
#190472   By "regulatory blockage" I guess you refer to genisi 04/25/15 11:50:56 AM
#190471   To date, eight of 13 GT1a patients had willyw 04/25/15 10:39:56 AM
#190470   ENANTA PHARMACEUTICALS ANNOUNCES PRELIMINARY DATA FROM ABBVIE’S PHASE pollyvonwog 04/25/15 10:16:26 AM
#190469   MYL PRGO TEVA The Unintended Twist of Tax Inversions zipjet 04/25/15 10:15:42 AM
#190468   MYL management will have to decide just how zipjet 04/25/15 09:46:01 AM
#190467   {{How did such a disparity come about? (I vinmantoo 04/25/15 02:47:09 AM
#190466   addendum to the MRK data: dewophile 04/24/15 10:07:18 PM
#190465   CRBP > Corbus looks interesting on a number mcbio 04/24/15 09:02:50 PM
#190464   Oops—I always found ImClone’s pipeline perplexing, LOL. DewDiligence 04/24/15 08:20:26 PM
#190463   Thanks a lot! I really made me wonder dangerM 04/24/15 06:07:06 PM
#190462   "Confirm negatively" means that it's on schedule, and frontiers 04/24/15 05:42:35 PM
#190461   >> Cyramza is the “fully human Erbitux" Need correction jq1234 04/24/15 05:28:09 PM
#190460   Well, to answer dangerM 04/24/15 04:59:55 PM
#190459   AERI certainly hasn’t given up yet, but they'll DewDiligence 04/24/15 04:57:51 PM
#190458   LLY—FDA approves new Cyramza indication—second-line CRC in conjunction DewDiligence 04/24/15 04:53:51 PM
PostSubject